Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
With proper medical supervision, these risks can be significantly reduced
Superior Weight Loss Results: In the REDEFINE 1 trial, CagriSema achieved an average weight loss of 22.7% in adults with obesity, outperforming semaglutide (16.1%) and cagrilintide (11.8%) used alone
Cusi, K
(5.3) Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Make changes to a patient's insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) under close medical supervision with increased frequency of blood glucose monitoring
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
